Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Onyx Gold Announces Trading Debut and Introduces Executive Team and Exploration Plans
-
Form 8.3 - [EMIS Group plc - 21 07 2023] - (CGWL)
-
AtriCure to Participate at Upcoming Investor Conferences
-
CANACCORD GENUITY GROUP INC. ACCESS TO FIRST QUARTER FISCAL 2024 RESULTS INFORMATION
-
Form 8.3 - [EMIS Group plc - 19 07 2023] - (CGWL)
-
SI-BONE to Present at Canaccord Genuity 43rd Annual Growth Conference on August 9, 2023
-
Aurora (AUR) Prices Upsized 73.33M Share Offering at $3/sh
-
Aurora Announces Pricing of $220 Million Upsized Public Offering of Class A Common Stock
-
Form 8.3 - [EMIS Group plc - 18 07 2023] - (CGWL)
-
New Relic Announces Date of First Quarter Fiscal Year 2024 Financial Results Conference Call and Participation in an Upcoming Investor Conference
-
Shockwave Medical Announces Details for Conference Call Discussing Second Quarter 2023 Results and Participation in Upcoming Investor Conference
-
ACV to Report Second Quarter 2023 Financial Results and Participate in the Canaccord Genuity 43rd Annual Growth Conference
-
Nerdy to Participate in Canaccord Genuity Annual Growth Conference
-
Canaccord Genuity Upgrades Lilium N.V. (LILM) to Buy Following Recent Financing
-
Form 8.3 - [EMIS Group plc - 14 07 2023] - (CGWL)
-
Rhythm Pharmaceuticals to Report Second Quarter 2023 Financial Results on Tuesday, August 1, 2023
-
Crescat Capital Seizes Opportunity with $2 Million Investment in Tectonic Metals Ahead of Drills Turning in August at Flat Gold Project
-
Olink to report second quarter 2023 financial results on August 9, 2023, and to participate in the Canaccord Genuity 43rd Annual Growth Conference
-
Blue Apron to Present at Upcoming August Investor Conferences
-
Form 8.3 - [Best of the Best plc - 12 07 2023] - (CGAML)
-
Form 8.3 - [EMIS Group plc - 12 07 2023] - (CGWL)
-
Orecap Appoints Gautam Iyer as VP Corporate Development
-
Form 8.3 - [EMIS Group plc - 11 07 2023] - (CGWL)
-
Nevro to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Thor Explorations Announces Q2 2023 Operating Update
-
Hemisphere Energy Announces Normal Course Issuer Bid Renewal
-
Northern Superior Announces Spinout Transaction for Ontario Assets, Including the District Scale TPK Project
-
Canaccord Genuity Starts Lithium Ionic Corp (LTH:CN) at Spec. Buy
-
Iris Energy (IREN) Issues Monthly Investor Update for June 2023
-
Iris Energy Announces Monthly Investor Update for June 2023
-
Form 8.3 - [EMIS Group plc - 05 07 2023] - (CGWL)
-
Criterium Energy Announces Pricing of Public Offering in Connection with Transformative Acquisition
-
Form 8.3 - [Cenkos Securities plc - 03 07 2023] - (CGAML)
-
Form 8.3 - [EMIS Group plc - 03 07 2023] - (CGWL)
-
Canaccord Genuity Assumes Theratechnologies Inc. (THTX) at Hold
-
Form 8.3 - [EMIS Group plc - 30 06 2023] - (CGWL)
-
Arrow Announces Total Voting Rights (TVR) Update
-
Form 8.3 - [EMIS Group plc - 29 06-2023] - (CGWL)
-
Form 8.3 - [FireAngel Safety Technology Group plc - 28 06 2023] - (CGAML)
-
Eli Lilly & Co. (LLY) to Acquire Sigilon Therapeutics (SGTX) for $14.92/sh plus CVR
-
Lilly to Acquire Sigilon Therapeutics
-
Microstrategy (MSTR) buys another 12,333 bitcoins, averaging down and sitting in the green
-
Microstrategy (MSTR) acquired approximately 12,333 bitcoins for approximately $347.0 million in cash
-
Red Light Holland Announces Shares Buyback Under Normal Course Issuer Bid
-
Canaccord Genuity Starts MedAdvisor Ltd (MDR:AU) at Buy
-
Form 8.3 - [EMIS GROUP PLC] 27 06 2023 - (CGWL)
-
E SPLIT CORP. Completes Overnight Offering of Approximately $33.3 Million
-
Form 8.3 - [EMIS GROUP PLC] 26 06 2023 - (CGWL)
-
enCore Energy (EU) Announces $70M ATM Offering
-
Canaccord Genuity Starts Supremex Inc (SXP:CN) at Buy

